Literature DB >> 7994095

Hypothermic circulatory arrest and other methods of cerebral protection during operations on the thoracic aorta.

M A Ergin1, E B Griepp, S L Lansman, J D Galla, M Levy, R B Griepp.   

Abstract

Current surgical techniques in operations on the thoracic aorta frequently require exclusion of the cerebral circulation for varying periods. During these periods, hypothermic circulatory arrest (HCA), selective cerebral perfusion (SCP), and retrograde cerebral perfusion (RCP) can be used for cerebral protection. Hypothermia is the principle component of these methods of protection. The main protective effect of hypothermia is based on reduction of cerebral energy expenditures and largely depends on adequate suppression of cerebral function. It is most effective at deep hypothermic levels (13 degrees C to 15 degrees C). Measures that preserve autoregulation of cerebral blood flow help increase the margin of safety with all methods of protection. There is solid experimental and clinical data indicating the safe limits and outcome following HCA. Current applications of SCP and RCP are fairly recent developments and do not have comparable supporting data. SCP can be used without deep hypothermia and allows prolonged periods of cerebral protection, but is complex in application. RCP is simpler, but always requires deep hypothermia. Present clinical data do not allow separation of its protective effect from that of HCA alone. Recent modifications in the application of HCA include monitoring of cerebral O2 extraction, and selective use of supplemental SCP to limit arrest times to less than 50 minutes, or RCP to prevent embolic strokes, as indicated. These changes appear to have reduced the overall mortality, the severity of embolic strokes, and stroke-related mortality.

Entities:  

Mesh:

Year:  1994        PMID: 7994095     DOI: 10.1111/j.1540-8191.1994.tb00886.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  20 in total

Review 1.  [Type A dissection. Principles of anesthesiological management].

Authors:  J Roggenbach; H Rauch
Journal:  Anaesthesist       Date:  2011-02       Impact factor: 1.041

Review 2.  What blood pressure is appropriate for cardiopulmonary bypass and how to get it.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 3.  Advances in thoracic aortic surgery: arch replacement with axillary cannulation and thoracic stent grafts.

Authors:  François Dagenais; Eric Dumont; Patrick Mathieu; Pierre Voisine
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

4.  Best strategy for cerebral protection in arch surgery - antegrade selective cerebral perfusion and adequate hypothermia.

Authors:  Martin Misfeld; Friedrich W Mohr; Christian D Etz
Journal:  Ann Cardiothorac Surg       Date:  2013-05

5.  A reappraisal of retrograde cerebral perfusion.

Authors:  Yuichi Ueda
Journal:  Ann Cardiothorac Surg       Date:  2013-05

6.  Moderate hypothermic circulatory arrest in total arch repair for acute type A aortic dissection: clinical safety and efficacy.

Authors:  Ming Gong; Wei-Guo Ma; Xin-Liang Guan; Long-Fei Wang; Jia-Chen Li; Feng Lan; Li-Zhong Sun; Hong-Jia Zhang
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

Review 7.  Neuroprotective Strategies in Repair and Replacement of the Aortic Arch.

Authors:  Frank Manetta; Clancy W Mullan; Michael A Catalano
Journal:  Int J Angiol       Date:  2018-05-27

8.  Simple retrograde cerebral perfusion is as good as complex antegrade cerebral perfusion for hemiarch replacement.

Authors:  Akiko Tanaka; Anthony L Estrera
Journal:  J Vis Surg       Date:  2018-03-13

9.  Arch-first technique used with commercial T-graft to treat subacute type-A aortic dissection in patient with Marfan syndrome.

Authors:  Anil Z Apaydin; Hakan Posacioglu; Tahir Yagdi; Fatih Islamoglu; Tanzer Calkavur; Suat Buket
Journal:  Tex Heart Inst J       Date:  2002

10.  The Use of Hypothermic Circulatory Arrest During Heart Transplantation Does Not Worsen Posttransplant Survival.

Authors:  Robert A Sorabella; Laura Guglielmetti; Amanda Bader; Andres Gomez; Koji Takeda; Paul J Chai; Hiroo Takayama; Emile A Bacha; Yoshifumi Naka; Isaac George
Journal:  Ann Thorac Surg       Date:  2016-05-19       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.